期刊文献+

基因芯片和比例法药物敏感性试验检测结核分枝杆菌对利福平和异烟肼耐药性的比较研究 被引量:37

The comparative study of gene chip and ratio drug sensitive test in detecting Mycobacterium tuberculosis resistance to rifampin and isoniazid
下载PDF
导出
摘要 目的比较基因芯片和比例法药物敏感性试验在检测结核分枝杆菌(MTB)对利福平(RFP)和异烟肼(INH)耐药性中的应用,探讨快速诊断耐多药结核病(MDR-TB)的方法。方法从改良罗氏培养基上分离的327株菌株,分别用基因芯片检测MTB对RFP和INH耐药相关的rpoB、katG和inhA基因上8个位点的基因突变,从而判断其耐药性;同时用比例法药物敏感性试验检测MTB对RFP和INH耐药性,比较2种方法的符合率。进一步从二者RFP或/和INH结果不符的标本中随机选出16株菌株做DNA序列测定,比较二者与DNA测序的符合率。结果基因芯片和比例法药物敏感性试验检测MTB对RFP耐药性符合率为93.27%,对INH耐药性符合率为95.11%,RFP和INH的总符合率为90.52%;二者对MDR-TB的检出率分别为18.65%和18.96%。基因芯片与DNA测序比较,RFP耐药性符合率为81.25%,INH耐药性符合率为100.00%;比例法药物敏感性试验与DNA测序比较,RFP耐药性符合率为50.00%,INH耐药性符合率为37.50%。结论基因芯片检测MTB对RFP和INH的耐药性较比例法药物敏感性试验有更高的敏感性和特异性,对MDR-TB的快速诊断具有重要临床价值。 Objective To study comparatively the application of gene chip and ratio drug sensitive test in detecting Mycobacterium tuberculosis (MTB) resistance to rifampin (RFP) and isoniazid(INH) , and investigate a rapid method for diagnosing multi-drug resistant tuberculosis (MDR-TB). Methods After isolating 327 strains from Lowenstein-Jensen, the gene mutation of the 8 sites in rpoB, katG and inhA genes related with MTB resistance to RFP and INH was detected, and the drug resistance was determined. Meanwhile, the ratio drug sensitive test was used to detect MTB resistance to RFP and INH, and the coincidence rates of RFP/INN were compared. Furthermore, 16 strains randomly from the samples which were not consistent with the results of RFP or/and INH were performed DNA sequencing, and then the coincidence rate with the DNA sequencing was compared. Results The coincidence rate of MTB resistance to RFP was 93.27% ,but that to INH was 95.11%. The coincidence rate of MTB resistance to RFP and INH was 90.52%. The detection rates of the 2 methods in detecting MDR-TB were 18.65% and 18.96% , respectively. Comparing the gene chip with DNA sequencing,the coincidence rate of RFP drug resistance was 81.25% , and that of INH drug resistance was 100. 00%. Comparing the ratio drug sensitive test with DNA sequencing, the coincidence rate of RFP drug resistance was 50.00% , and that of INH drug resistance was 37.50%. Conclusions The gene chip in detecting MTB resistance to RFP and INH has high sensitivity and specificity, and has an clinical significance in rapid diagnosis of MDR-TB.
机构地区 贵阳市肺科医院
出处 《检验医学》 CAS 2013年第5期404-407,共4页 Laboratory Medicine
关键词 基因芯片 比例法药物敏感性试验 结核分枝杆菌 Gene chip Ratio drug sensitive test Mycobacterium tuberculosis
  • 相关文献

参考文献9

  • 1中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 2Quy HT, Lan NT, Borgdorff MW, et al. Drug resistance among failure and relapse cases of tuberculosis : is the standard retreatment regimen adequate [ J ]. Int J Tuberc Lung Dis,2003,7 (7) : 631-636.
  • 3World Heahh Organization. Global tuberculosis control: epidemiology, strategy, financing [ R ]. Geneva : World Health Organization,2009.
  • 4He GX, Zhao YL, Jiang GL, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China [J]. BMC Infect Dis,2008,8:166.
  • 5吴雪琼.耐药性结核分枝杆菌的分子生物学研究现状[J].中华结核和呼吸杂志,2006,29(12):837-840. 被引量:29
  • 6Uys PW, Warren R, van Helden PD, et al. Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent [ J ]. J Clin Microbiol, 2009,47 ( 5 ) : 1484- 1490.
  • 7Bang D, Andersen PH, Andersen AB,et al. Isoniazid- resistant tuberculosis in Denmark: mutations, trans- mission and treatment outcome[ J]. J Infect, 2010,60 (6) :452-457.
  • 8周江,张万江.结核分枝杆菌对异烟肼和利福平耐药的研究进展[J].中国现代医药杂志,2011,13(1):111-114. 被引量:6
  • 9崔振玲,景奉香,胡忠义,吴自荣,赵建龙.基因芯片检测结核分枝杆菌利福平和异烟肼耐药性研究[J].中华结核和呼吸杂志,2004,27(7):439-441. 被引量:31

二级参考文献52

  • 1WU Xue-qiong,LIANG Jian-qin,ZHANG Jun-xian,LU Yang,LI Hong-min,ZHANG Guang-yu,YAN Guo-rui,DING Bei-chuan.Detection and evaluation of the mutations of embB gene in etham butol-susceptible and resistant Mycobacterium tuberculos isisolates from China[J].Chinese Medical Journal,2005(20):1739-1741. 被引量:4
  • 2Aziz MA, Laszlo A, Raviglione M, et al. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. World Health Organization,2003:102.
  • 3Stoicescu IP, Homorodean D, Chiotan D, et al. Romanian anti-TB drugs resistance surveillance 2003-2004. Pneumologia,2008,57: 131-137.
  • 4Mai NT Huyen,Edine W Tiemersma, Nguyen TN Lan,et al.Validation of the GenoType? MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam.BMC Infect Dis, 2010,10:149.
  • 5World Health Organization. Global tuberculosis control - surveillance, planning, financing. WHO report 2008. Geneva, World Health Organization,2008.
  • 6World Health Organization (WHO)/Intemational Union Against Tuberculosis and Lung Disease (IUATLD) Anti-tuberculosis drug resistance in the world: report 4. Geneva: WHO,2008.
  • 7World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. WHO/HTM/TB/ 2009.411. WHO, Geneva, Switzerland,2009.
  • 8Quy HT, Buu TN, Cobelens FG,et al. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis,2006,10(2):160-166.
  • 9Huong NT, Lan NT, Cobelens FG. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. J Infect Dis, 2006,194(9):1226-1232.
  • 10Quy HT, Lan NT, Borgdorff MW, et al.Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis,2003,7(7):631-636.

共引文献288

同被引文献330

引证文献37

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部